tiprankstipranks
Trending News
More News >
Telix Pharmaceuticals Ltd. (AU:TLX)
OTHER OTC:TLX
US Market

Telix Pharmaceuticals (TLX) Financial Statements

Compare
523 Followers

Telix Pharmaceuticals Financial Overview

Telix Pharmaceuticals's market cap is currently AU$3.71B. The company's EPS TTM is AU$0.057830210400000005; its P/E ratio is 219.88; Telix Pharmaceuticals is scheduled to report earnings on January 20, 2026, and the estimated EPS forecast is AU$0.09. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total RevenueAU$ 783.21MAU$ 502.55MAU$ 160.10MAU$ 7.60MAU$ 5.21M
Gross ProfitAU$ 509.68MAU$ 314.39MAU$ 29.34MAU$ -29.77MAU$ -16.88M
Operating IncomeAU$ 82.13MAU$ 51.89MAU$ -73.18MAU$ -81.25MAU$ -49.25M
EBITDAAU$ 92.55MAU$ 22.97MAU$ -92.84MAU$ -70.07MAU$ -54.20M
Net IncomeAU$ 49.92MAU$ 5.21MAU$ -104.08MAU$ -80.51MAU$ -44.89M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 710.35MAU$ 123.24MAU$ 116.33MAU$ 22.04MAU$ 77.94M
Total AssetsAU$ 1.52BAU$ 398.30MAU$ 255.35MAU$ 109.81MAU$ 157.82M
Total DebtAU$ 581.45MAU$ 17.45MAU$ 10.45MAU$ 2.54MAU$ 2.21M
Net DebtAU$ -128.90MAU$ -105.79MAU$ -105.88MAU$ -19.50MAU$ -75.74M
Total LiabilitiesAU$ 948.22MAU$ 249.39MAU$ 178.44MAU$ 106.17MAU$ 78.81M
Stockholders' EquityAU$ 568.21MAU$ 148.91MAU$ 80.01MAU$ 2.16MAU$ 79.02M
Cash Flow
Free Cash FlowAU$ 9.00MAU$ 13.09MAU$ -77.83MAU$ -60.67MAU$ 1.64M
Operating Cash FlowAU$ 43.03MAU$ 23.88MAU$ -63.97MAU$ -59.33MAU$ 1.96M
Investing Cash FlowAU$ -135.17MAU$ -25.49MAU$ -17.00MAU$ -2.73MAU$ -1.09M
Financing Cash FlowAU$ 638.92MAU$ 10.19MAU$ 174.96MAU$ 2.85MAU$ 34.12M
Currency in AUD

Telix Pharmaceuticals Earnings and Revenue History

Telix Pharmaceuticals Debt to Assets

Telix Pharmaceuticals Cash Flow

Telix Pharmaceuticals Forecast EPS vs Actual EPS